Form 4: Medpace Exec. VP Exercises Stock Options

Sentiment:

Insider Transaction Report 30 September 2025 4:15 PM

Medpace Holdings, Inc. Executive VP, Operations, Susan E. Burwig, exercised 10,000 employee stock options at $107.93 per share.

Summary

Susan E. Burwig, Executive VP, Operations of Medpace Holdings, Inc. (MEDP), exercised employee stock options on September 26, 2025.
Burwig acquired 10,000 shares of Common Stock by exercising options at a price of $107.93 per share.
Following this transaction, Burwig directly beneficially owns 67,500 shares of Common Stock.
The exercised options had vested in full on February 28, 2020, and were set to expire on February 28, 2026.
After the exercise, Burwig holds 30,984 derivative securities (employee stock options).

Sentiment

Score: 6

Explanation: The exercise of stock options by an executive is generally viewed as a neutral to slightly positive event, indicating the executive is realizing value from their compensation plan and potentially maintaining a stake in the company. It does not, however, provide new fundamental insights into the company's operational performance or strategic direction.

Positives

An executive exercising stock options can signal confidence in the company's future performance, as they are choosing to convert options into shares.
The exercise of options at a strike price of $107.93 indicates that the current market price is likely above this value, making the exercise profitable for the executive.

Future Outlook

Industry Context

Stakeholder Impact

Shareholders may view the executive's exercise of options as a minor positive signal of confidence in the company's value.

Key Dates

Date	Description
02/28/2020	Date when the employee stock option vested in full.
09/26/2025	Date of the transaction where 10,000 employee stock options were exercised.
09/30/2025	Date the Form 4 was signed by the attorney-in-fact for Susan E. Burwig.
02/28/2026	Expiration date of the employee stock option.

Recommendation

hold

This Form 4 filing details a routine insider transaction involving the exercise of employee stock options. While it indicates an executive realizing value from their compensation, it does not provide new material information about Medpace Holdings, Inc.'s financial performance, strategic outlook, or competitive position that would warrant a change in investment recommendation. Investors should consider this as a standard insider activity rather than a strong signal for buying or selling.

Keywords

Medpace, MEDP, insider transaction, stock option, Form 4, executive, beneficial ownership

Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.